Wells Fargo added Alkermes (ALKS) (AKLS) and Centessa (CNTA) to the firm’s Q4 2025 Tactical Ideas List. The firm sees upside to Centessa shares if the Alkermes’ alixorexton MWT result is 20-29 min or leaves room for improvement on tolerability. But Wells also thinks the downside to Alkermes is limited, and worth owning as Alkermes could surprise to the upside. The firm has Overweight ratings on both names.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS: